Figure A (Zomacton 01)
Zomacton Kit
Product Images NDC 55566-1901
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Zomacton (NDC 55566-1901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Zomacton 02)
This text is providing information about a syringe with a mixing needle and a medication called ZOMACTON 10mg.*
Figure C (Zomacton 03)
The text is not clear and contains several errors and non-English characters. Therefore, the description cannot be generated.*
Figure D (Zomacton 04)
Figure E (Zomacton 05)
Figure F (Zomacton 06)
Figure G (Zomacton 07)
Figure H (Zomacton 08)
Figure I (Zomacton 09)
Figure J (Zomacton 10)
Figure K (Zomacton 11)
Figure L (Zomacton 12)
Figure M (Zomacton 13)
Figure N (Zomacton 14)
Figure O (Zomacton 15)
Figure P (Zomacton 16)
Figure Q (Zomacton 17)
Figure R (Zomacton 18)
Figure S (Zomacton 19)
Figure T (Zomacton 20)
Figure U (Zomacton 21)
Figure V (Zomacton 22)
Principal Display Panel (5 mg Vial Label)
ZOMACTON 5mg is a medication for subcutaneous injection containing 5mg of somatropin, a growth hormone that stimulates cell regeneration and reproduction in humans, and 30mg of mannitol. Each package comes with one vial of ZOMACTON and one vial of bacteriostatic 0.9% sodium chloride injection, USP. ZOMACTON is to be reconstituted with bacteriostatic 0.9% sodium chloride injection, USP and refrigerated. The medication should not be frozen and must be used within 14 days of reconstitution. The usual dosage is contained in the package insert. The medication was made in Germany for Ferring Pharmaceuticals Inc. in the USA.*
Principal Display Panel (5 mL Diluent Vial Label)
ZOMACTON 10mg (somatropin) for injection is a drug from Germany containing 10 mg of somatropin lyophilized with 10 mg of mannitol. The package includes a vial of ZOMACTON (somatropin) for Injection 10 mg, a prefilled diluent syringe, and a needle attachment. Each prefilled syringe contains 1 mL of bacteriostatic water for injection containing 0.33% m-cresol as an antimicrobial preservative. The reconstituted solution has a pH of 7.0 - 0.0. The package insert should be consulted for the usual dosage. The drug is manufactured by Ferring Pharmaceuticals, NJ, USA.*
Principal Display Panel (5 mg Kit Carton)
ZOMACTON 10mg is a medication for injection containing somatropin. Each vial contains 10 mg of somatropin lyophilized with 10 mg of mannitol. The prefilled syringe contains 1 mL of Bacteriostatic water for reconstitution. The solution has a pH of 7.0 - 0.0 and contains 0.33% metacresol as an antimicrobial preservative. The usual dosage is to be determined with package insert guidelines. The medication is for subcutaneous use only and should be refrigerated at 2°C to 8°C. The reconstituted vial should be used within 28 days and kept away from light. It should only be used with the needle-free ZOMA-Jet 10. The medication is manufactured in Germany and distributed by Ferring Pharmaceuticals Inc. in Parsippany, NJ, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
